Latest Breaking News On - குறுகிய வடிவம் ஆரோக்கியம் கணக்கெடுப்பு - Page 1 : comparemela.com
Women with Psoriatic Arthritis Experience Higher Disease Activity, Different Treatment Response
practicalpainmanagement.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from practicalpainmanagement.com Daily Mail and Mail on Sunday newspapers.
Chronic fatigue a significant challenge for most long COVID patients
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial
News provided by
Share this article
Share this article
1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the phase III China clinical trial (PaTHway China Trial) of TransCon PTH Solution for Injection (TransCon™ parathyroid hormone).
2. PaTHway China Trial is designed to assess the potential of TransCon™ PTH as a hormone replacement therapy, and the aim is to enable patients to have serum calcium (sCa) within the normal range and independence from usual care.
vimarsana © 2020. All Rights Reserved.